ALK-Abelló A/S

alk

ALK-Abelló A/S is an international pharmaceutical company devoted to improve the lives of people with allergies by developing pharmaceuticals products that target the cause of allergy.

ALK-Abelló A/S is the world leader in allergy vaccination (immunotherapy) – a unique treatment including a protective immune response that reduces and potentially halts the allergic reaction.

For further information: www.alk.net

Lundbeckfonden

News

New analytical method exposes the body’s policemen
19. November 2018
The world’s only cubed poop can now be scientifically explained
19. November 2018
Genetic sprint – all the way down through the Americas
9. November 2018